Company news

DRI Healthcare Trust news in 2025

DRI Healthcare Trust's news releases, calls and decks from 2025, newest first.

View company

DRI Healthcare Reports Third Quarter 2025 Results

November 5, 2025

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

October 20, 2025

DRI Healthcare to Host Third Quarter 2025 Earnings Call and Webcast on November 6, 2025

October 16, 2025

DRI Healthcare Trust Promotes Zaheed Mawani to Chief Financial Officer

September 19, 2025

DRI Healthcare to Present at Upcoming Investor Conferences

September 16, 2025

DRI Healthcare Reports Second Quarter 2025 Results

August 13, 2025

DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025

July 24, 2025

DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetralstat)

July 8, 2025

DRI Healthcare Announces Closing of Internalization Transaction

July 1, 2025

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints

June 13, 2025

DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee

June 9, 2025

DRI Healthcare Trust Announces Voting Results of AGM

May 13, 2025

DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager

May 12, 2025

DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025

April 22, 2025

Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

March 5, 2025

DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

March 3, 2025

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

January 29, 2025

Decks in 2025